Late-phase trials of targeted therapies for elevated lipoprotein(a) are nearing completion, with the first readouts expected later this year.
May 28, 2026
6 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
PHILADELPHIA — With several lipoprotein(a) therapies nearing market availability, physicians at the Heart in Diabetes CME…
A single lipoprotein(a) screening in a person’s lifetime could significantly reduce their risk for heart disease-related…
Find the latest Vascular Medicine news articles, videos, podcasts, and meeting coverage from medical experts and key opinion…
We are living in an exciting new era for Alzheimer’s treatment. For the first time, therapies can slow the disease for some…
Suneel Kamath, MD, knows too well the sense of helplessness that comes with living through what he calls “the doughnut…
Studies show that GLP-1 receptor agonists have significant potential for treating glaucoma, diabetic retinopathy and other eye…
